Crédit Industriel et Commercial’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Crédit Industriel et Commercial’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-80,000	Closed	-$768K	–	452
2024 Q4	$768K	Buy	+80,000	New	+$417K	0.1%	194

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Crédit Industriel et Commercial's PSTX Position: Q1 2025 in Review

Crédit Industriel et Commercial sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 80,000 shares — an estimated $768K sold.

Crédit Industriel et Commercial first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $768K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Crédit Industriel et Commercial reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 80,000 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $768K.
Crédit Industriel et Commercial first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Crédit Industriel et Commercial's Poseida Therapeutics, Inc. Common Stock position peaked at $768K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2025, filed 15 May 2025.